C R Bard Inc (BCR) News| Reuters.com
Edition:
United States

C R Bard Inc (BCR)

BCR on New York Consolidated

226.16USD
24 Jun 2016
Change (% chg)

$-4.53 (-1.96%)
Prev Close
$230.69
Open
$225.08
Day's High
$228.64
Day's Low
$224.96
Volume
396,954
Avg. Vol
481,420
52-wk High
$229.61
52-wk Low
$169.09

Select another date:

Wed, May 4 2016

BRIEF-C R Bard prices note offering

* Priced public offering of 10-year senior notes in aggregate principal amount of $500 million and with interest rate of 3% per year Source (http://bit.ly/1OeKDKZ) Further company coverage:

BRIEF-C R Bard CEO Timothy Ring's fy 2015 total compensation was $11.7 mln - sec filing

* Says coo john weiland's fy 2015 total compensation $6.9 million versus $7.0 million in fy 2014

4th Circuit won't let four mesh cases out of C.R. Bard MDL

A federal appeals court has rejected a request from four plaintiffs suing C.R. Bard over transvaginal mesh to let their cases leave the West Virginia court where they have been consolidated with thousands of similar claims in multidistrict litigation.

Boston Scientific, C.R. Bard win defense verdicts in mesh trial

A Missouri jury has cleared medical device manufacturers Boston Scientific and C.R. Bard of liability in the first trial involving a woman who said she was injured by transvaginal mesh devices made by more than one company.

Select another date: